An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?

Glioblastoma multiforme (GBM) is a primary type of lethal brain tumor. Over the last two decades, temozolomide (TMZ) has remained the primary chemotherapy for GBM. However, TMZ resistance in GBM constitutes an underlying factor contributing to high rates of mortality. Despite intense efforts to unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Teraiya, Milan, Perreault, Helene, Chen, Vincent C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169742/
https://www.ncbi.nlm.nih.gov/pubmed/37182181
http://dx.doi.org/10.3389/fonc.2023.1166207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169742/
https://www.ncbi.nlm.nih.gov/pubmed/37182181
http://dx.doi.org/10.3389/fonc.2023.1166207

Ejemplares similares